KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Evolent Health (EVH) Enterprise Value (2016 - 2025)

Evolent Health has reported Enterprise Value over the past 11 years, most recently at -$178.0 million for Q4 2025.

  • Quarterly results put Enterprise Value at -$178.0 million for Q4 2025, down 8.86% from a year ago — trailing twelve months through Dec 2025 was -$178.0 million (down 8.86% YoY), and the annual figure for FY2025 was -$178.0 million, down 8.86%.
  • Enterprise Value for Q4 2025 was -$178.0 million at Evolent Health, down from -$140.4 million in the prior quarter.
  • Over the last five years, Enterprise Value for EVH hit a ceiling of -$112.9 million in Q3 2024 and a floor of -$342.0 million in Q4 2021.
  • Median Enterprise Value over the past 5 years was -$204.6 million (2022), compared with a mean of -$209.1 million.
  • Biggest five-year swings in Enterprise Value: tumbled 136.59% in 2021 and later soared 45.64% in 2024.
  • Evolent Health's Enterprise Value stood at -$342.0 million in 2021, then skyrocketed by 40.73% to -$202.7 million in 2022, then fell by 1.92% to -$206.6 million in 2023, then increased by 20.86% to -$163.5 million in 2024, then decreased by 8.86% to -$178.0 million in 2025.
  • The last three reported values for Enterprise Value were -$178.0 million (Q4 2025), -$140.4 million (Q3 2025), and -$175.4 million (Q2 2025) per Business Quant data.